Literature DB >> 19588219

M-protein-positive chronic active Epstein-Barr virus infection: features mimicking HIV-1 infection.

Shinsaku Imashuku1, Naoto Azuma2, Hirokazu Kanegane3, Yoshihito Kasahara4.   

Abstract

Chronic active Epstein-Barr virus infection (CAEBV) is a unique and fatal lymphoproliferative disease (LPD), which often shows high serum IgG and/or IgE. The significance of such immunoglobulin abnormalities in CAEBV has not been fully evaluated and discussed. In addition, such clinical features mimic HIV-1 infection. We report here a case of CAEBV with M-protein detected which may shed a new light on the pathogenesis of this disease.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19588219     DOI： 10.1007/s12185-009-0373-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.319


  23 in total

1.  Polyclonal proliferation of plasma cells associated with marked hypergammaglobulinemia in an elderly patient.

Authors:  Hitoshi Ohno; Hideaki Tanaka; Hisashi Sakai; Tatsuya Katsurada; Yataro Yoshida
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

Review 2.  Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection.

Authors:  Motohiko Okano; Keisei Kawa; Hiroshi Kimura; Akihiro Yachie; Hiroshi Wakiguchi; Akihiko Maeda; Shosuke Imai; Shouichi Ohga; Hirokazu Kanegane; Shigeru Tsuchiya; Tomohiro Morio; Masaaki Mori; Shumpei Yokota; Shinsaku Imashuku
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

3.  14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.

Authors:  H Avet-Loiseau; T Facon; A Daviet; C Godon; M J Rapp; J L Harousseau; B Grosbois; R Bataille
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

4.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.

Authors:  N Raab-Traub; K Flynn
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

Review 5.  Mechanisms of IgE elevation in HIV-1 infection.

Authors:  G Marone; G Florio; M Triggiani; A Petraroli; A de Paulis
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

6.  Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patients.

Authors:  G B Olson; M N Kanaan; G M Gersuk; L M Kelley; J F Jones
Journal:  J Allergy Clin Immunol       Date:  1986-08       Impact factor: 10.793

Review 7.  Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.

Authors:  R A Kyle
Journal:  Hematol Oncol Clin North Am       Date:  1997-02       Impact factor: 3.722

8.  A case of reactive plasmacytosis mimicking multiple myeloma in a patient with primary Sjogren's syndrome.

Authors:  Jisoo Lee; Ji-Eun Chang; Young-Joo Cho; Woon Seop Han
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

9.  Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.

Authors:  Emiko Sato; Shouichi Ohga; Hiroshi Kuroda; Fumiaki Yoshiba; Miki Nishimura; Masayuki Nagasawa; Masami Inoue; Keisei Kawa
Journal:  Am J Hematol       Date:  2008-09       Impact factor: 10.047

10.  Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

Authors:  Luciano J Costa; Shaji Kumar; Angela Dispenzieri; Suzanne E Hayman; Francis K Buadi; David Dingli; Mark R Litzow; Morie A Gertz; Martha Q Lacy
Journal:  Leuk Lymphoma       Date:  2009-05
View more
  1 in total

1.  Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis.

Authors:  Ayako Arai; Ken-Ichi Imadome; Yuko Watanabe; Mayumi Yoshimori; Takatoshi Koyama; Takeharu Kawaguchi; Chiaki Nakaseko; Shigeyoshi Fujiwara; Osamu Miura
Journal:  Int J Hematol       Date:  2011-04-14       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.